Consistent with these findings, siRNA against IDH1 under low glucose conditions substantially reduced OCR in melanoma cells (Fig. 3E and F), with negligible effects under high glucose conditions (Supplementary Fig. S2E). The gene discussed is IDH1; the disease is melanoma.